In response to Body letter to the editor regarding "safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):318-9. (correspondence) Conte P, Guarneri V. In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):315-6. (correspondence)
The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View
CONTE, PIERFRANCO;GUARNERI, VALENTINA;
2005
Abstract
In response to Body letter to the editor regarding "safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):318-9. (correspondence) Conte P, Guarneri V. In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):315-6. (correspondence)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
